110 results in Exploration of Neuroprotective Therapy
Most Cited
  • Latest
  • Most Viewed
  • Most Downloaded
  • Most Cited
Sort by :
Open Access Review
Striking a balance: PIP2 and PIP3 signaling in neuronal health and disease
Kamran Tariq, Bryan W. Luikart
Published: October 29, 2021 Explor Neuroprot Ther. 2021;1:86–110
This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases
11357 339 34
Open Access Review
Blocking cholesterol storage to treat Alzheimer’s disease
Ta Yuan Chang ... James G. Gow
Published: December 30, 2021 Explor Neuroprot Ther. 2021;1:173–184
This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases
5107 112 19
Open Access Review
Pathophysiology of non-motor signs in Parkinson’s disease: some recent updating with brief presentation
Khaled Radad ... Wolf-Dieter Rausch
Published: February 27, 2023 Explor Neuroprot Ther. 2023;3:24–46
12922 283 17
Open Access Review
Advancing diagnosis and treatment of Niemann-Pick C disease through biomarker discovery
Xuntian Jiang, Daniel S. Ory
Published: December 30, 2021 Explor Neuroprot Ther. 2021;1:146–158
This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases
4413 103 17
Open Access Review
Subarachnoid hemorrhage: management considerations for COVID-19
Eric J. Panther, Brandon Lucke-Wold
Published: March 02, 2022 Explor Neuroprot Ther. 2022;2:65–73
This article belongs to the special issue Emerging Concepts in Subarachnoid Hemorrhage
6168 68 15
Open Access Review
The glymphatic system and subarachnoid hemorrhage: disruption and recovery
Stephan Quintin ... Brandon Lucke-Wold
Published: June 21, 2022 Explor Neuroprot Ther. 2022;2:118–130
This article belongs to the special issue Emerging Concepts in Subarachnoid Hemorrhage
4703 112 12
Open Access Review
Balancing cholesterol in the brain: from synthesis to disposal
Lydia Qian ... Andrew J. Brown
Published: January 05, 2022 Explor Neuroprot Ther. 2022;2:1–27
This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases
14929 475 12
Open Access Review
Biomarkers in neurodegenerative diseases: a broad overview
Sathish Selvam, Velpandi Ayyavoo
Published: April 16, 2024 Explor Neuroprot Ther. 2024;4:119–147
This article belongs to the special issue The Future of Biomarkers in CNS Diseases
9673 237 12
Open Access Review
Targeting α-synuclein aggregation with immunotherapy: a promising therapeutic approach for Parkinson’s disease
Gabriela Henriquez, Mahesh Narayan
Published: August 25, 2023 Explor Neuroprot Ther. 2023;3:207–234
7583 174 11
Open Access Review
Economics of dry needling and botulinum toxin type A for treatment of post-stroke spasticity: a review
Daniel Fernández ... Eva María Gómez-Trullén
Published: June 30, 2022 Explor Neuroprot Ther. 2022;2:131–140
This article belongs to the special issue Dry Needling for Neurological Disorders
3113 81 8
Open Access Review
T-cell based immunotherapies for Parkinson’s disease
Rodrigo Pacheco
Published: October 29, 2021 Explor Neuroprot Ther. 2021;1:72–85
4924 156 8
Open Access Systematic Review
Various facets of excitotoxicity
Talita Glaser ... Henning Ulrich
Published: February 23, 2022 Explor Neuroprot Ther. 2022;2:36–64
10312 202 7
Open Access Perspective
Gut microbiota could modulate the effects of neuro-immune responses and memory traces via the gut-brain-immune axis in schizophrenia
Haruka Sawamura ... Satoru Matsuda
Published: April 24, 2022 Explor Neuroprot Ther. 2022;2:74–86
This article belongs to the special issue Intervention of Neuroimmune Responses
8689 2201 6
Open Access Review
Exploration of transcutaneous vagus nerve stimulation as a treatment option for adjuvant cancer and heart failure therapy
Niklas Frank ... Carola Y. Förster
Published: October 31, 2023 Explor Neuroprot Ther. 2023;3:363–397
This article belongs to the special issue Intervention of Neuroimmune Responses
7044 78 6
Open Access Review
Can chronic therapeutic drug use by the elderly affect Alzheimer’s disease risk and rate of progression?
Rafael Franco, Joan Serrano-Marín
Published: February 27, 2023 Explor Neuroprot Ther 2023;3:8–23
2571 42 5
Open Access Review
Neuroprotective astroglial response to neural damage and its relevance to affective disorders
José Javier Miguel-Hidalgo
Published: October 31, 2023 Explor Neuroprot Ther. 2023;3:328–345
2687 29 5
Open Access Review
Potentialities of IGF-1 for regulating oxidative stress in neuroinflammation and neurodegeneration: theoretical review
Macarena Lorena Herrera ... Claudia Beatriz Hereñú
Published: October 31, 2024 Explor Neuroprot Ther. 2024;4:442–458
3317 52 5
Open Access Original Article
Combined effects of dry needling and exercises therapy on muscle spasticity and motor function in chronic stroke: a pretest-posttest pilot study
Seyedeh Saeideh Babazadeh-Zavieh ... Korosh Mansoori
Published: June 20, 2022 Explor Neuroprot Ther. 2022;2:100–109
This article belongs to the special issue Dry Needling for Neurological Disorders
3393 89 4
Open Access Perspective
Can meditation-based approaches improve the cleansing power of the glymphatic system?
Peter Wostyn, Piet Goddaer
Published: June 20, 2022 Explor Neuroprot Ther. 2022;2:110–117
8240 158 4
Open Access Review
Targeting cytochrome P450 46A1 and brain cholesterol 24-hydroxylation to treat neurodegenerative diseases
Irina A. Pikuleva
Published: December 30, 2021 Explor Neuroprot Ther. 2021;1:159–172
This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases
3929 100 4